Antibiotics Market Size, Share & Trends Report

Antibiotics Market Size, Share & Trends Analysis Report By Drug Class (Cephalosporin, Penicillin), By Type, By Action Mechanism (RNA Synthesis Inhibitors, Cell Wall Synthesis Inhibitors), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-1-68038-149-8
Number of Pages: 150
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry:Healthcare

Market Segmentation

Antibiotics Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamides
- 7-ACA
- Others
Antibiotics Type Outlook (Revenue, USD Million, 2018 - 2030)
- Branded
- Generic
Antibiotics Action Mechanism Outlook (Revenue, USD Million, 2018 - 2030)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
- Others
Antibiotics Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-aminocephalosporanic acid (7-ACA)
    - Others
  - North America Antibiotics Market, By Type
    - Branded Antibiotics
    - Generic Antibiotics
  - North America Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - U.S.
    - U.S. Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - U.S. Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - U.S. Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Canada
    - Canada Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Canada Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Canada Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
- Europe
  - Europe Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-aminocephalosporanic acid (7-ACA)
    - Others
  - Europe Antibiotics Market, By Type
    - Branded Antibiotics
    - Generic Antibiotics
  - Europe Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - UK
    - 英国Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - 英国Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - 英国Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Germany
    - Germany Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Germany Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Germany Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - France
    - France Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - France Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - France Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Italy
    - Italy Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Italy Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Italy Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Spain
    - Spain Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Spain Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Spain Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Denmark
    - Denmark Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Denmark Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - 丹麦抗生素市场的作用机理
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Norway
    - Norway Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Norway Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Norway Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Sweden
    - Sweden Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Sweden Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Sweden Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
- Asia Pacific
  - Asia Pacific Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-aminocephalosporanic acid (7-ACA)
    - Others
  - Asia Pacific Antibiotics Market, By Type
    - Branded Antibiotics
    - Generic Antibiotics
  - Asia Pacific Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - Japan
    - Japan Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Japan Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Japan Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - China
    - China Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - China Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - China Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - India
    - India Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - India Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - India Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - South Korea
    - South Korea Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - South Korea Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - South Korea Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Australia
    - Australia Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Australia Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Australia Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Thailand
    - Thailand Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Thailand Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Thailand Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
- Latin America
  - Latin America Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-aminocephalosporanic acid (7-ACA)
    - Others
  - Latin America Antibiotics Market, By Type
    - Branded Antibiotics
    - Generic Antibiotics
  - Latin America Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - Brazil
    - Brazil Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Brazil Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Brazil Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Argentina
    - Argentina Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Argentina Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Argentina Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Mexico
    - Mexico Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Mexico Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Mexico Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
- Middle East and Africa
  - Middle East and Africa Antibiotics Market, By Drug Class
    - Cephalosporin
    - Penicillin
    - Fluoroquinolone
    - Macrolide
    - Carbapenem
    - Aminoglycoside
    - Sulfonamide
    - 7-aminocephalosporanic acid (7-ACA)
    - Others
  - Middle East and Africa Antibiotics Market, By Type
    - Branded Antibiotics
    - Generic Antibiotics
  - Middle East and Africa Antibiotics Market, By Action Mechanism
    - Cell Wall Synthesis Inhibitors
    - Protein Synthesis Inhibitors
    - DNA Synthesis Inhibitors
    - RNA Synthesis Inhibitors
    - Mycolic Acid Inhibitors
    - Others
  - South Africa
    - South Africa Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - South Africa Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - South Africa Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Saudi Arabia
    - Saudi Arabia Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Saudi Arabia Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Saudi Arabia Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - UAE
    - UAE Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - UAE Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - UAE Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others
  - Kuwait
    - Kuwait Antibiotics Market, By Drug Class
      - Cephalosporin
      - Penicillin
      - Fluoroquinolone
      - Macrolide
      - Carbapenem
      - Aminoglycoside
      - Sulfonamide
      - 7-aminocephalosporanic acid (7-ACA)
      - Others
    - Kuwait Antibiotics Market, By Type
      - Branded Antibiotics
      - Generic Antibiotics
    - Kuwait Antibiotics Market, By Action Mechanism
      - Cell Wall Synthesis Inhibitors
      - Protein Synthesis Inhibitors
      - DNA Synthesis Inhibitors
      - RNA Synthesis Inhibitors
      - Mycolic Acid Inhibitors
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
乐鱼体育手机网站入口
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report -free of charge- including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read ourprivacy policy.